Drug
Ab308
Ab308: highest development phase Phase 1, developed by Arcus Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Arcus Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| AB308 NCT04772989 | Phase 1 | Advanced Solid Tumor |
Latest
No recent events.
Follow Ab308 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.